Philips adds 1-tesla magnet to NT line

Article

The MRI division of PhilipsMedical Systems enjoyed a banner year thanks to its Gyroscan NTline, 1.5- and 0.5-tesla systems introduced at last year's RSNAmeeting (SCAN 12/29/93). While other vendors lamented the sorrystate of the MRI market this year,

The MRI division of PhilipsMedical Systems enjoyed a banner year thanks to its Gyroscan NTline, 1.5- and 0.5-tesla systems introduced at last year's RSNAmeeting (SCAN 12/29/93). While other vendors lamented the sorrystate of the MRI market this year, Philips set a pace to doubleits volume of MRI sales over 1993, according to Chris Farr, MRImarketing director.

Philips' performance was all the more remarkable consideringit was accomplished without an offering in the popular 1-teslasegment. That's due to change at next week's meeting, when Philipswill debut a 1-tesla Gyroscan NT scanner.

Philips has never sold a 1-tesla MRI offering, Farr said, butthe vendor has determined that the 1-tesla niche is simply toobig to ignore. The U.S. MRI market is dividing into thirds, withthe 1.5-tesla, 1-tesla and 0.5-tesla segments equally represented,according to Farr.

The 1-tesla NT will have all the functionality of the 1.5-teslamagnet, including echo-planar imaging and GRASE fast scanning.The 1-tesla NT is awaiting FDA 510(k) clearance.

In other modalities, Philips will show a mobile CT scannerbeing developed by Analogic (SCAN 11/9/94). Philips is one oftwo companies with which Analogic signed an OEM agreement, accordingto a Philips spokesperson in Shelton, CT. The identity of theother OEM has not been released.

Philips will display a new mobile C-arm, BV 212. The unit featuresa 12-inch image intensifier to enable clinicians to see more anatomyduring interventional studies. BV 212 has FDA clearance.

Philips will also debut EasyGuide Neuro, an image-guided surgeryworkstation. The system uses a light pen to register the positionof surgical instruments to image data contained in the workstation,according to the company.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.